These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2349631)

  • 1. Donor selection for alloimmunized patients by platelet crossmatching of random-donor platelet concentrates.
    O'Connell BA; Schiffer CA
    Transfusion; 1990 May; 30(4):314-7. PubMed ID: 2349631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: solid-phase platelet crossmatching to support the alloimmunized patient.
    O'Connell BA
    Immunohematology; 1995; 11(4):150-2. PubMed ID: 15447057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of lymphocytotoxic antibody reactivity on the results of single antigen mismatched platelet transfusions to alloimmunized patients.
    Hussein MA; Lee EJ; Fletcher R; Schiffer CA
    Blood; 1996 May; 87(9):3959-62. PubMed ID: 8611727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
    Sintnicolaas K; Löwenberg B
    Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.
    Kickler TS; Ness PM; Braine HG
    Am J Clin Pathol; 1988 Jul; 90(1):69-72. PubMed ID: 3389345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates.
    O'Connell BA; Lee EJ; Rothko K; Hussein MA; Schiffer CA
    Blood; 1992 Jan; 79(2):527-31. PubMed ID: 1730095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
    Heal JM; Blumberg N; Masel D
    Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ineffectiveness of random donor platelet transfusion in splenectomized, alloimmunized recipients.
    Hogge DE; Dutcher JP; Aisner J; Schiffer CA
    Blood; 1984 Jul; 64(1):253-6. PubMed ID: 6733276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
    JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial measurement of lymphocytotoxic antibody and response to nonmatched platelet transfusions in alloimmunized patients.
    Lee EJ; Schiffer CA
    Blood; 1987 Dec; 70(6):1727-9. PubMed ID: 3479195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of enzyme-linked immunoassay platelet crossmatching for transfusion of platelet concentrates to alloimmunized recipients.
    Brubaker DB; Duke JC; Romine M
    Am J Hematol; 1987 Apr; 24(4):375-87. PubMed ID: 3551590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet crossmatching with lymphocytotoxicity test: an effective method in alloimmunized Chinese patients.
    Chow MP; Yung CH; Hu HY; Tzeng JL; Lin WM; Lin CK
    Transfusion; 1991 Sep; 31(7):595-9. PubMed ID: 1891789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.
    Gelb AB; Leavitt AD
    Transfusion; 1997 Jun; 37(6):624-30. PubMed ID: 9191823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.
    Friedberg RC; Donnelly SF; Mintz PD
    Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet crossmatches of single-donor platelet concentrates using a latex agglutination assay.
    Ogden DM; Asfour A; Koller C; Lichtiger B
    Transfusion; 1993 Aug; 33(8):644-50. PubMed ID: 8342230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immune globulin for patients alloimmunized to random donor platelet transfusion.
    Lee EJ; Norris D; Schiffer CA
    Transfusion; 1987; 27(3):245-7. PubMed ID: 3590287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion.
    Hogge DE; Dutcher JP; Aisner J; Schiffer CA
    Am J Hematol; 1983 Jun; 14(4):363-9. PubMed ID: 6859034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
    Menitove JE; Duquesnoy RJ
    Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective evaluation of flow cytometry as a platelet crossmatching procedure.
    Gates K; MacPherson BR
    Cytometry; 1994 Sep; 18(3):123-8. PubMed ID: 7813332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.